Chats with Michael Marquardt, American Cancer Society Board Member and Philanthropist
Join Michael Marquardt, Immediate Past Chair of the American Cancer Society National Board of Directors, for an invitation-only series of live fireside chats. Each session will feature a different guest and cover a variety of priority mission topics and will provide attendees an opportunity to engage in the discussion during the Q&A segment.
To request an invitation, contact your local Philanthropy Director.
Michael Marquardt
Immediate Past Chair
Fireside chat series
- Past Events
Fireside Chat with Michael Marquardt, ACS Board Member and Philanthropist: Population Science at ACS
April 11, 2023
The Population Science Department is an intramural research program of the American Cancer Society (ACS) which conducts innovative research focused on understanding cancer risk factors and how to improve the quality of life and survival for people with cancer. The Department uses the collective expertise of epidemiologists, biostatisticians, behavioral scientists, research analysts, and study management experts to better understand the behavioral, social, physical, environmental, and societal factors that affect cancer prevention, risk, treatment and survivorship.
Guest: Alpa Patel, PhD
Connect with our National Board Chair: The Surveillance and Health Equity Science (SHES) Department
December 7, 2022
The Surveillance and Health Equity Science (SHES) Department is an intramural research program of the American Cancer Society (ACS). Our staff includes world-renowned epidemiologists and health scientists, and we're among the most comprehensive cancer surveillance, health services, and disparities research groups worldwide. The goal of the SHES department is to conduct interdisciplinary, impactful research and disseminate information on cancer occurrence, prevention, early detection, treatment, survivorship, and economic burden to inform delivery of cancer care and cancer prevention and control nationally and globally in support of the ACS mission.
Guest: Ahmedin Jemal, DVM, PhD
Connect with our National Board Chair: Rallying Together to Influence Change
October 26, 2022
For 20 years the American Cancer Society Cancer Action Network (ACS CAN) has been empowering volunteers to influence change and impact the future of cancer. From gaining dramatic increases in funding for cancer research to ensuring all Americans have access to cancer care, our work is saving lives and leading to new innovative breakthroughs in how to fight this disease.
Michael and President of the nonpartisan advocacy affiliate of the ACS, Lisa Lacasse, have an insightful discussion about the organization she leads in support of laws and policies that help people fight cancer and advance the ACS’ mission.
Guest: Lisa Lacasse, President, ACS CAN
Connect with our National Board Chair: Meet the first ACS Chief Patient Officer
September 14, 2022
Michael and American Cancer Society Chief Patient Officer, Dr. Arif Kamal, discuss the Society’s patient-facing activities. Dr. Kamal leads the development and implementation of strategic plans to measurably improve the lives of cancer patients and their families.
Guest: Dr. Arif Kamal, ACS Chief Patient Officer
Connect with our National Board Chair: What does it take to outsmart cancer?
June 15, 2022
Research. The American Cancer Society has invested more than $5 billion in cancer research since 1946, all to find more – and better – treatments, uncover factors that may cause cancer, and improve cancer patients' quality of life. Learn more about the power of the ACS research program.
Guest: Dr. Gregg Semenza, Past ACS Research Professor and 2019 Nobel Prize winner
Connect with our National Board Chair: What’s Next for ACS?
April 20th 2022
Karen and Michael reflected on key mission accomplishments achieved during her first year as CEO and provided insight regarding plans to enhance our organizational impact.
Guest: Dr. Karen E. Knudsen, CEO, ACS and ACS CAN
Connect with our National Board Chair: The American Cancer Society has a Venture Fund?
March 2nd 2022
Michael and Alice engaged in a conversation about how BrightEdge propels groundbreaking patient-centric solutions by investing in the most innovative startup companies to advance science, reduce disparities, and promote health care sustainability.
Guest: Alice Pomponio, Vice President Innovation & Impact Investing / Managing Director, BrightEdge
Help us end cancer as we know it, for everyone.
